(Q44573270)

English

Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial

scientific article published on 29 August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial (English)

1 reference

Europe PubMed Central

4 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

H Morii

1

1 reference

Europe PubMed Central

4 December 2017

Y Ohashi

2

1 reference

Europe PubMed Central

4 December 2017

Y Taketani

3

1 reference

Europe PubMed Central

4 December 2017

M Fukunaga

4

1 reference

Europe PubMed Central

4 December 2017

T Nakamura

5

1 reference

Europe PubMed Central

4 December 2017

A Itabashi

6

1 reference

Europe PubMed Central

4 December 2017

S Sarkar

7

1 reference

Europe PubMed Central

4 December 2017

K Harper

8

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

29 August 2003

1 reference

Europe PubMed Central

4 December 2017

Osteoporosis International

1 reference

Europe PubMed Central

4 December 2017

14

1 reference

Europe PubMed Central

4 December 2017

793-800

1 reference

Europe PubMed Central

4 December 2017

10

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1007/s00198-003-1424-1

0 references

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual X-ray absorptiometry quality control: comparison of visual examination and process-control charts

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnosis of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The medical dictionary for regulatory activities (MedDRA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative calibration without a gold standard

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12955333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00198-003-1424-1

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44573270&oldid=2028482334"